Distinguished Research Fellow
Institute of Biomedical Sciences, Academia Sinica
Taipei, United States
After completing his clinical training and becoming a certified cardiovascular surgeon in Taiwan, Dr. Hsieh went to the US for his PhD degree in bioengineering and postdoctoral training in cardiac stem cell therapy and nanomedicine. Since back to Taiwan in 2006, Dr. Hsieh focuses his research on cardiovascular regeneration, cancer nanomedicine, microbiota and metabolism, iPSC technologies and translational research. He is the principle investigator of several flagship projects in Taiwan, and leads the Taiwan iPSC Consortium (2015~), the Taiwan Tissue Chip Project (2016-2020) and the Taiwan Precision Regenerative Medicine project (2022~), working on establishing Taiwan’s superdonor iPS cell bank for clinical cell therapy. Dr. Hsieh has received many awards and honors, including National Innovation Award (twice), Ministry of Science and Technology Outstanding Research Award (twice), Teco Award, Taiwan Bio-developmental Foundation Chair Award, Outstanding Alumnus Award of Kaohsiung Medical University and National Heath Research Institutes Merit Award. He was elected to International Fellow of American Heart Association, and was recognized as a top translational researcher by Nature Biotechnology. Dr. Hsieh has published 110 scientific papers including those in Nature Medicine, Science Translational Medicine, Journal of Clinical Investigation, Circulation, Circulation Research, PNAS, Science Advances, Nature Communications and ACS Nano. He has filed more than 40 international patents, tech-transferred to two domestic companies, collaborated with global big pharma/biotech companies (Gilead, AZ, Celgene, Takeda & Moderna) and has applied his research results into clinical therapy for cardiovascular regenerative medicine.
Disclosure information not submitted.
Friday, October 25, 2024
10:00 AM - 11:00 AM EST